Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Forma Therapeutics Holdings, Inc. - Common Stock (NQ:FMTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 19.98 (496)
Ask (Size) 20.01 (1,384)
Prev. Close 20.01
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 47,852,557
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biotech Stocks Well-Positioned For The Fourth Quarter ↗
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far. 
Via Talk Markets
News headline image
Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes ↗
 
Via Benzinga

Performance

More News

Read More
News headline image
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease
From Forma Therapeutics, Inc.
Via Business Wire
News headline image
FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
4 Analysts Have This to Say About Forma Therapeutics Hldgs ↗
Via Benzinga
News headline image
Recap: Forma Therapeutics Q2 Earnings ↗
Via Benzinga
News headline image
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗
Via Investor's Business Daily
News headline image
Top Russell 2000 Stocks: Trading Opportunities For Next Week - Sunday, Sept. 11 ↗
Via Talk Markets
News headline image
FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022 ↗
Via Benzinga
News headline image
This Analyst Predicts $700 For Broadcom, Plus RBC Capital Slashes PT On This Stock By 85% ↗
Via Benzinga
News headline image
Dow Turns Higher; Gold Down 1% ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗
Via Benzinga
News headline image
Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply ↗
Via Benzinga
News headline image
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session ↗
Via Benzinga
News headline image
Novo Nordisk Jumps Into Sickle Cell Fray With $1.1 Billion Forma Therapeutics Buyout ↗
Via Investor's Business Daily
News headline image
Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
Guardforce AI (GFAI) Stock Gets a Boost From New Exec Team ↗
Via InvestorPlace
News headline image
Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News ↗
Via InvestorPlace
News headline image
After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal ↗
Via Benzinga
News headline image
FMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Forma Therapeutics, Holdings Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
News headline image
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders
From Forma Therapeutics
Via Business Wire
News headline image
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
From Forma Therapeutics Holdings, Inc.
Via Business Wire
News headline image
Earnings Scheduled For August 5, 2022 ↗
Via Benzinga

Frequently Asked Questions

Is Forma Therapeutics Holdings, Inc. - Common Stock publicly traded?
Yes, Forma Therapeutics Holdings, Inc. - Common Stock is publicly traded.
What exchange does Forma Therapeutics Holdings, Inc. - Common Stock trade on?
Forma Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Forma Therapeutics Holdings, Inc. - Common Stock?
The ticker symbol for Forma Therapeutics Holdings, Inc. - Common Stock is FMTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.